Clara L Rodriguez-Bernal
Overview
Explore the profile of Clara L Rodriguez-Bernal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
519
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Ibanez P, Marco-Moreno I, Garcia-Sempere A, Peiro S, Martinez-Ibanez L, Barreira-Franch I, et al.
JAMA Netw Open
. 2024 May;
7(5):e2410063.
PMID: 38728033
Importance: Patient empowerment through pharmacologic self-management is a common strategy for some chronic diseases such as diabetes, but it is rarely used for controlling blood pressure (BP). Several trials have...
2.
Hurley E, Geisler B, Lupattelli A, Poblador-Plou B, Lassalle R, Jove J, et al.
Eur J Clin Pharmacol
. 2024 Feb;
80(5):707-716.
PMID: 38347228
Purpose: The COVID-19 pandemic has impacted medication needs and prescribing practices, including those affecting pregnant women. Our goal was to investigate patterns of medication use among pregnant women with COVID-19,...
3.
Martinez-Ibanez P, Marco-Moreno I, Peiro S, Martinez-Ibanez L, Barreira-Franch I, Bellot-Pujalte L, et al.
J Gen Intern Med
. 2022 Oct;
38(1):81-89.
PMID: 36219303
Background: Patient empowerment through pharmacological self-management is a common strategy in some chronic diseases such as diabetes, but it is rarely used for controlling blood pressure. Objective: This study aimed...
4.
Rodriguez-Bernal C, Sanchez-Saez F, Bejarano-Quisoboni D, Hurtado I, Garcia-Sempere A, Peiro S, et al.
Front Cardiovasc Med
. 2022 Jun;
9:863876.
PMID: 35694663
Aim: Adherence to multiple medications recommended for secondary prevention of cardiovascular conditions represents a challenge. We aimed to identify patterns of concurrent adherence to combined therapy and assess their impact...
5.
Llopis-Cardona F, Armero C, Hurtado I, Garcia-Sempere A, Peiro S, Rodriguez-Bernal C, et al.
J Bone Miner Res
. 2022 Apr;
37(6):1200-1208.
PMID: 35441744
Osteoporotic hip fractures in older people may confer an increased risk of subsequent hip fractures and death. The aim of this study was to estimate the cumulative incidence of both...
6.
Rodriguez-Bernal C, Sanchez-Saez F, Bejarano-Quisoboni D, Riera-Arnau J, Sanfelix-Gimeno G, Hurtado I
Front Pharmacol
. 2021 Dec;
12:789783.
PMID: 34966283
Despite the continuous update of clinical guidelines, little is known about the real-world management of patients with atrial fibrillation (AF) who survived a stroke. We aimed to assess patterns of...
7.
Iftimi A, Rodriguez-Bernal C, Peiro S, Bonanad S, Ferrero-Gregori A, Hurtado I, et al.
Clin Pharmacol Ther
. 2021 Jul;
111(1):200-208.
PMID: 34242404
The association between the use of vitamin K antagonists (VKAs) and cancer risk reduction remains unclear. We aimed to assess the association between the use of VKAs or direct oral...
8.
Marco-Moreno I, Martinez-Ibanez P, Avelino-Hidalgo E, Bellot-Pujalte L, Barreira-Franch I, Martinez-Ibanez L, et al.
BJGP Open
. 2020 Aug;
4(4).
PMID: 32816741
Background: Despite the increased use of blood pressure (BP) monitoring devices at home, the hypertension of more than 50% of European patients remains uncontrolled. Nevertheless, the self-management of BP, through...
9.
Rodriguez-Bernal C, Santa-Ana-Tellez Y, Garcia-Sempere A, Hurtado I, Peiro S, Sanfelix-Gimeno G
Br J Clin Pharmacol
. 2020 Jun;
87(2):632-643.
PMID: 32530052
Aims: Acenocoumarol is a vitamin-K antagonist (VKA) primarily used in certain countries (e.g. India, Netherlands, Spain). The half-life of acenocoumarol is similar to that of non-VKA oral anticoagulants (NOAC), unlike...
10.
Rodriguez-Bernal C, Garcia-Sempere A, Hurtado I, Santa-Ana Y, Peiro S, Sanfelix-Gimeno G
BMJ Open
. 2018 Dec;
8(12):e025102.
PMID: 30573490
Introduction: Atrial fibrillation (AF) is one of the leading causes of cerebrovascular mortality and morbidity. Oral anticoagulants (OACs) have been shown to reduce the incidence of cardioembolic stroke in patients...